Hyldstrup L, Christiansen C, Nielsen M D, Transbøl I
Scand J Clin Lab Invest. 1984 Jun;44(4):335-9. doi: 10.3109/00365518409083816.
Hormonal changes after arginine-induced growth hormone stimulation and subsequent testosterone treatment were examined in 5 patients classified as having male delayed puberty. All the patients responded well to growth hormone stimulation and a significant negative correlation was found between the delay in height age and the maximal growth hormone response, r = 0.80, P less than 0.05. The testosterone treatment did not alter this pattern. Changes in PTH, 25OHD, 24.25(OH)2D, and 1.25(OH)2D were examined at 24 h after the infusion. The results showed significant reductions in PTH (P less than 0.05) and 24.25 (OH)2D (P less than 0.05) and a possible increase in 1.25(OH)2D, whereas 25OHD remained unchanged. These results may support the conception of growth hormone as a common denominator of growth and bone metabolism.
对5例诊断为男性青春期延迟的患者,研究了精氨酸诱导生长激素刺激及随后睾酮治疗后的激素变化。所有患者对生长激素刺激反应良好,身高年龄延迟与最大生长激素反应之间存在显著负相关,r = 0.80,P < 0.05。睾酮治疗未改变这种模式。在输注后24小时检测了甲状旁腺激素(PTH)、25羟维生素D(25OHD)、24,25-二羟维生素D[24,25(OH)2D]和1,25-二羟维生素D[1,25(OH)2D]的变化。结果显示PTH(P < 0.05)和24,25(OH)2D(P < 0.05)显著降低,1,25(OH)2D可能升高,而25OHD保持不变。这些结果可能支持生长激素作为生长和骨代谢共同因素的概念。